[1] JEONG H, HWANG I, KANG S H,et al.Tumor-associated macrophages as potential prognostic biomarkers of invasive breast cancer[J].Breast Cancer,2019, 22(1):38-51. [2] 马守宝,林丹丹,刘海燕.炎症细胞因子在肿瘤微环境中的作用及其作为治疗靶点的研究进展[J].生命科学,2016,28(2):182-191. [3] MOONEY S M,RAJAGOPALAN K,RANGARAJAN G, et al. Cancer/testis antigens and obligate participation in multiple hallmarks of cancer:an update[J]. Asian J Androl, 2016, 18(5):711-712. [4] 魏智民,孙玉发,李刚,等.癌症相关性炎症与肿瘤微环境相关研究进展[J].中国肿瘤临床,2018,45(21):1117-1121. [5] KITAMURA T,QIAN B Z,POLLARD J W.Immune cellpromotion of metastasis[J]. Nat Rev Immunol,2015,15(2):73-86. [6] SHEN M,WANG J,YU W W,et al. A novel MDSC-induced PD-1-PD-L1+B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties[J].Oncoimmunology,2018,7(4):e1413520. [7] LUONG B,SCHWENK R,BRAUTIGAM J,et al.The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen[J].PLoS One,2018,13(9):e0203053. [8] LEBLEU V S,KALLURI R.A peek into cancer-associated fibroblasts:origins, functions and translational impact[J]. Dis Model Mech,2018,11(4):dmm029447. [9] YANG J E,LU Y,LIN Y Y,et al.Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma[J].Cancer Lett,2016,383(1):18-27. [10] DELGADO-BELLIDO D,SERRANO-SAENZ S,FERNÁNDEZ-CORTÉ S,et al.Vasculogenic mimicry signaling revisited:focus on non-vascular VE-cadherin[J].Mol Cancer,2017,16(1):65. [11] MILLS C D. Anatomy of a discovery:m1 and m2 macrophages[J].Front Immunol,2015,6:212. [12] SORMENDI S,WIELOCKX B.Hypoxia pathway proteins as central mediators of metabolism in the tumor cells and their microenvironment[J].Front Immunol,2018,9:40-47. [13] 孙林冲,高平.代谢重编程在调控肿瘤免疫微环境中的作用[J].生物化学与生物物理进展,2017,44(8):688-696. [14] ZHANG LJ, LU R Q, SONG YN, et al. Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling[J]. Sci Rep, 2017, 7(1):6362. [15] WANG X,LI M.Correlate tumor mutation burden with immunes ignatures in human cancers[J].BMC Immunol,2019,20(1):4. [16] 李杏,王丹丹,唐琪,等.巨噬细胞极化的转录调控及其对相关疾病影响的研究进展[J].吉林大学学报(医学版),2016,42(3):622-626. [17] TSAI H F,TRUBELJA A,SHEN A Q,et al.Tumour-on-a-chip:microfluidic models of tumour morphology,growth and microenvironment[J]. J R Soc Interface,2017,14(131):20170137. [18] YATES LR,KNAPPSKOG S,W EDGE D,et al.Genomic evolution of breast cancer metastasis and relapse[J].Cancer Cell,2017,32(2):169-184. [19] SOMASUNDARAM R,ZHANG G,FUKUN M,et al.Tumor-associated B-cells induce tumor heterogeneity and therapy resistance[J]. Nat Commun,2017,8(1): 607-615. [20] HIDA K,MAISHI N,ANNAN D,et al.Contribution of tumor endothelial cells in cancer progression[J]. Int J Mol Med,2018,19(5):2306-2317. |